ASML vs CACI

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

CACI exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency. While the current price of $516.54 is significantly above the defensive Graham Number ($313.75), it trades at a substantial discount to its growth-based intrinsic value of $688.83 and analyst targets. Despite bearish short-term technicals and insider selling, the company's consistent track record of earnings beats and double-digit EPS growth support a long-term bullish outlook.